share_log

クリングルファーマ:声帯瘢痕に対するHGF(肝細胞増殖因子)の第III相臨床試験における治験実施施設(山王メディカルセンター)の追加について

KRINGLE PHARMA: Addition of clinical trial implementation facilities (Sanno Medical Center) to phase III clinical trials of HGF (hepatocyte growth factor) for vocal cord scars

JPX ·  May 16 02:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more